TABLE 2.
Colonization Status Throughout Enrollment
| Organism | Probiotic (n = 30) | Standard of Care (n =40) | P value |
|---|---|---|---|
| Colonization at enrollment | |||
| ESBL/CRE | 0 (0) | 1 (3)a | >.99 |
| VRE | 7 (23) | 5 (13) | .34 |
| Pseudomonas aeruginosa | 1 (3) | 0 (0) | .43 |
| Clostridium difficile | 6 (20) | 9 (23) | .80 |
| Acquisition of colonizationb | |||
| ESBL/CRE | 2/30 (7) | 0/39 (0) | .19 |
| VRE | 4/23 (17) | 3/35 (9) | .42 |
| P. aeruginosa | 2/29 (7) | 3/40 (8) | >.99 |
| C. difficile | 0/24 (0) | 2/31 (6) | .50 |
| Loss of colonizationc | |||
| ESBL/CRE | N/A | 0/1 (0) | |
| VRE | 0/7 (0) | 0/5 (0) | |
| P. aeruginosa | 0/1 (0) | N/A | |
| C. difficile | 0/6 (0) | 1/9 (11) | >.99 |
NOTE. CRE, carbapenem-resistant Enterobactcriaceae; ESBL, extended-spectrum beta-lactamase; N/A, not applicable; VRE, vancomycin-resistant Enterococcus.
a
This was ESBL.
b
Negative culture results on enrollment and positive culture results on day 3 and/or study exit, excluding those colonized at day 0.
c
Positive culture results on enrollment and negative culture results on day 3 and/or study exit.